Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, anticoagulation therapy, bone, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid and liver disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus and infectious diseases. The company's diagnostic solutions include blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol and coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring and therapy; electrolytes analysis; emergency medicine; hemostasis, heterogeneous immunochemistry, homogeneous immuno assay, immunology, and infectious disease solutions; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control services; real-time PCR diagnostic systems; urinalysis; and serum work area and workflow solutions. In addition, it offers gene expression, gene sequencing, and real time PCR systems for researchers. The company licenses its products or technologies to third parties. Roche Holding AG has collaboration agreements with San Francisco-based Syapse and KAHR Medical. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone41 61 688 11 11
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees94,442
Next Earnings DateN/A
OptionableNot Optionable
Roche (OTCMKTS:RHHVF) Frequently Asked Questions
What is Roche's stock symbol?
Roche trades on the OTCMKTS under the ticker symbol "RHHVF."
What is the consensus analysts' recommendation for Roche?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Roche.
Has Roche been receiving favorable news coverage?
Media stories about RHHVF stock have trended negative recently, InfoTrie reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Roche earned a news impact score of -2.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Roche.
Who are some of Roche's key competitors?
What other stocks do shareholders of Roche own?
Who are Roche's key executives?
Roche's management team includes the folowing people:
- Dr. Severin Schwan, CEO & Exec. Director (Age 52)
- Dr. Alan Hippe, Chief Financial & IT Officer (Age 52)
- Dr. Gottlieb A. Keller, Gen. Counsel & Corp. Sec. (Age 65)
- Ms. Cristina A. Wilbur, Head of Group HR (Age 52)
- Dr. Karl Mahler, Head of Investor Relations
How do I buy shares of Roche?
Shares of RHHVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Roche's stock price today?
One share of RHHVF stock can currently be purchased for approximately $301.69.
What is Roche's official website?
How can I contact Roche?
The company can be reached via phone at 41 61 688 11 11.
MarketBeat Community Rating for Roche (OTCMKTS RHHVF)
MarketBeat's community ratings are surveys of what our community members think about Roche and other stocks. Vote "Outperform" if you believe RHHVF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHHVF will underperform the S&P 500 over the long term. You may vote once every thirty days.
